The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR <i>ob</i>/<i>ob</i> type 2 diabetic mice with and without hypertension

• 資料種別: 記事
• タイトル: The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR <i>ob</i>/<i>ob</i> type 2 diabetic mice with and without hypertension
• 著者標目: Florian Gembardt; Christoph Bartaun; Natalia Jarzebska; Eric Mayoux; Vladimir T. Todorov; Bernd Hohenstein; Christian Hugo
• 出版年月日等: 2014-08-01
• 出版年（W3CDTF）: 2014-08-01
• タイトル（掲載誌）: American Journal of Physiology-Renal Physiology
• 巻号年月日等（掲載誌）: 307 3
• 掲載巻: 307
• 掲載号: 3
• 掲載ページ: F317-F325
• 掲載年月日（W3CDTF）: 2014-08-01
• ISSN（掲載誌）: 1931857X
• 出版事項（掲載誌）: American Physiological Society
• 対象利用者: 一般
• DOI: 10.1152/ajprenal.00145.2014
• 作成日（W3CDTF）: 2014-06-19
• 関連情報（URI）: https://www.physiology.org/doi/pdf/10.1152/ajprenal.00145.2014
• 参照: Failure to confirm a sodium-glucose cotransporter 2 inhibitor-induced hematopoietic effect in non-diabetic rats with renal anemia.; https://cir.nii.ac.jp/crid/1050285299984424448; Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial; https://cir.nii.ac.jp/crid/1050304183897563776; SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy; https://cir.nii.ac.jp/crid/1360283695654611200; Cardiorenal protective effects of sodium-glucose cotransporter 2 inhibition in combination with angiotensin II type 1 receptor blockade in salt-sensitive Dahl rats; https://cir.nii.ac.jp/crid/1360298338422956928; SGLT2阻害薬（ルセオグリフロジン）の血糖低下作用機序と合併症進展抑制の可能性; https://cir.nii.ac.jp/crid/1390282679252483968; Highlighted Paper selected by Editor-in-Chief : Acute and Direct Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glomerular Filtration Rate in Spontaneously Diabetic Torii Fatty Rats; https://cir.nii.ac.jp/crid/1390564227317033728
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Crossref; https://www.crossref.org

• 要約等: <jats:p> Diabetic nephropathy is the leading cause of end-stage renal disease in humans in the Western world. The recent development of Na<jats:sup>+<...